FDA Clears New Surgical Platform Combining Robotics & Magnetics

Levita Magnetics has achieved a significant milestone with FDA clearance for its pioneering abdominal surgery platform, which seamlessly integrates proprietary magnetic surgical technology with robotic assistance. This breakthrough not only upholds the well-established advantages for patients, including reduced incisions, decreased pain, minimal scarring, and accelerated recovery, but also elevates surgical precision and control for the operating surgeons. Levita initially introduced its magnetic surgery system to the commercial market back in 2016, with a primary focus on enhancing the minimally invasive aspects of abdominal surgeries, notably gallbladder removal. The introduction of this new platform signifies a substantial leap forward in surgical efficiency, realized through the harmonious fusion of magnetic and robotic technologies. This achievement underscores Levita's commitment to advancing surgical practices and highlights the promising potential for further innovation at the intersection of robotic assistance and magnetic surgical techniques in the field of abdominal surgery.